This website uses cookies to enhance the user experience.
I

INHERIT CARBON SOLUTIONS AS927 688 859

Research
Limited company
Otto Ruges vei 43B 1361 ØSTERÅS, Norge

INHERIT CARBON SOLUTIONS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
3 years
since Sep 9, 2021
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
290,759
1 share class
Total number of shareholders
7
companies

Financials

Total operating income 2023
314,600
NOK
Annual total result 2023
-4,249,053
NOK
Total equity 2023
2,681,913
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
39.55 %
indirectly

Board

NameRoleShares
Chairman-
Board Member-
KV
Board Member
39.55 %
indirectly
Board Member-
Board Member-
Alternate Member-

Others

NameRoleShares
H
HASLESTAD REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO
39.55 %
indirectly
KV
Board Member
39.55 %
indirectly
Last update: Mar 12, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
K
KAJA VOSS HOLDING AS
Ordinary shares
115,000
39.55 %
M
Ordinary shares
115,000
39.55 %
E
EQUINOR VENTURES AS
Ordinary shares
35,267
12.13 %
Ordinary shares
14,567
5.01 %
S
STRATEL AS
Ordinary shares
7,667
2.64 %
H
HONNINGKRUKKEN VENTURES AS
Ordinary shares
2,875
0.99 %
M
MELLBYESLAGSVOLD AS
Ordinary shares
383
0.13 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year20232022
Total operating income
314,600
349,990
Annual Total Result
-4,249,053
-1,130,939
Total assets
12,843,630
7,232,734
Total liabilities
10,161,717
727,167
Total equity
2,681,913
6,505,567

P&L

Year20232022
Total operating income
314,600
349,990
Total operating costs
5,787,036
1,796,215
Operating result
-5,472,436
-1,446,225
Financial income/costs
26,253
0
Profit before tax
-5,446,182
-1,446,225
Total tax & extraordinary income/cost
-1,197,129
-315,286
Annual Total Result
-4,249,053
-1,130,939

Balance overview

Year20232022
Total fixed assets
11,616,505
352,676
Total current assets
1,227,125
6,880,058
Total assets
12,843,630
7,232,734
Short term debt
10,161,717
727,167
Long term debt
0
0
Total liabilities
10,161,717
727,167
Contributed capital
8,189,961
7,764,560
Retained earnings
-5,508,047
-1,258,994
Total equity
2,681,913
6,505,567
Total equity and liabilities
12,843,630
7,232,734

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology